According to the news of the "Science and Technology Innovation Board Daily" on January 18, Jingtai Technology announced that it has reached a strategic cooperation with Chia Tai Tianqing, and the two sides will jointly develop small molecule new drugs for the treatment of malignant tumors for high-difficulty targets. Among them, Jintai Technology will use its artificial intelligence and high-precision computational chemistry and other technology platforms to complete the generation, evaluation and optimization of compounds, focusing on the discovery and optimization of small molecule anti-tumor innovative drugs.
According to wisdom bud data, as of the latest, Shenzhen Jintai Technology Co., Ltd. has published more than 130 patent applications. The company's current patented technology mainly focuses on crystal structure, organic molecules, molecular force fields, compounds, databases, computing platforms, cloud computing, small molecules and other technical fields.
![A new round of PD-1 inner rolls began, killing K pills and spending hundreds of millions of dollars just to go to sea[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)